Author Correction: Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial

Affiliations

• ¹ Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China.
• ² Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute, Beijing, China. zhqfan@bjmu.edu.cn.
• ³ Beijing Chao Yang Hospital, Breast Disease Department, Beijing, China.
• ⁴ Cancer Hospital, Chinese Academy of Medical Sciences, Breast Cancer Department, Beijing, China.
• ⁵ Peking University People's Hospital, Breast Cancer Center, Beijing, China.
• ⁶ Beijing Tsinghua Changgeng Hospital, Breast Disease Department, Beijing, China.
• ⁷ Xuan Wu Hospital Capital Medical University, Breast Disease Department, Beijing, China.
• ⁸ 307 Hospital of PLA, Breast Cancer Department, Beijing, China.
• ⁹ Peking University First Hospital, Breast Cancer Center, Beijing, China.